Paying users zone. Data is hidden behind: .
Get 1-month access to Gilead Sciences Inc. for $17.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Gilead Sciences Inc. pages available today for free:
Price to Operating Profit (P/OP)
since 2005
Calculation
Gilead Sciences Inc., P/OP, long-term trends, calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Income (loss) from operations1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2018 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2017 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2016 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2015 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2014 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2013 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2012 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2011 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2010 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2009 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2008 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2007 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2006 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2005 | = | ÷ | = | ÷ |
Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Gilead Sciences Inc.’s Annual Report.
Comparison to Competitors
Gilead Sciences Inc., P/OP, long-term trends, comparison to competitors
| Gilead Sciences Inc. | Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Biogen Inc. | Illumina Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | ||||||||
| Dec 31, 2018 | ||||||||
| Dec 31, 2017 | ||||||||
| Dec 31, 2016 | ||||||||
| Dec 31, 2015 | ||||||||
| Dec 31, 2014 | ||||||||
| Dec 31, 2013 | ||||||||
| Dec 31, 2012 | ||||||||
| Dec 31, 2011 | ||||||||
| Dec 31, 2010 | ||||||||
| Dec 31, 2009 | ||||||||
| Dec 31, 2008 | ||||||||
| Dec 31, 2007 | ||||||||
| Dec 31, 2006 | ||||||||
| Dec 31, 2005 |
Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).